Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| AGIOS PHARMACEUTICALS, INC. | 50,650 | reported | 04 Mar 2019 | tx 42+295,950−123,259 |
| Oric Pharmaceuticals, Inc. | 40,000 | reported | 02 Jan 2026 | tx 6+204,633 |
| C4 Therapeutics, Inc. | 35,500 | reported | 18 Jun 2025 | tx 2+100,500 |
| MBX Biosciences, Inc. | 11,938 | reported | 01 May 2026 | tx 9+295,938 |
| Clovis Oncology, Inc. | 0 | reported | 05 Mar 2015 | tx 19+280,000−120,000 |
| Ignyta, Inc. | 0 | reported | 08 Feb 2018 | tx 4+35,666−35,666 |
| CONSTELLATION PHARMACEUTICALS INC | 0 | reported | 15 Jul 2021 | tx 9+65,855−92,197 |
| Deciphera Pharmaceuticals, Inc. | 0 | reported | 11 Jun 2024 | tx 46+1,889,797−2,725,797 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 01 May 2026 | GRANT_AWARD | MBX Biosciences, Inc. | 11,938 | 0.00 USD | |
| 01 May 2026 | GRANT_AWARD | MBX Biosciences, Inc. | 74,249 | 0.00 USD | deriv |
| 02 Jan 2026 | GRANT_AWARD | Oric Pharmaceuticals, Inc. | 40,000 | 0.00 USD | deriv |
| 22 Nov 2025 | GRANT_AWARD | MBX Biosciences, Inc. | 8,000 | 0.00 USD | deriv |
| 06 Nov 2025 | GRANT_AWARD | MBX Biosciences, Inc. | 100,000 | 0.00 USD | deriv |
| 17 Oct 2025 | PURCHASE | MBX Biosciences, Inc. | 20,000 | 13.25 USD | |
| 18 Jun 2025 | GRANT_AWARD | C4 Therapeutics, Inc. | 35,500 | 0.00 USD | deriv |
| 05 Jun 2025 | GRANT_AWARD | MBX Biosciences, Inc. | 16,000 | 0.00 USD | deriv |
| 07 Apr 2025 | GRANT_AWARD | MBX Biosciences, Inc. | 32,000 | 0.00 USD | deriv |
| 02 Jan 2025 | GRANT_AWARD | Oric Pharmaceuticals, Inc. | 35,000 | 0.00 USD | deriv |
| 19 Nov 2024 | GRANT_AWARD | C4 Therapeutics, Inc. | 65,000 | 0.00 USD | deriv |
| 12 Jun 2024 | GRANT_AWARD | Oric Pharmaceuticals, Inc. | 25,600 | 0.00 USD | deriv |
| 11 Jun 2024 | GRANT_AWARD | Deciphera Pharmaceuticals, Inc. | 286,075 | — | |
| 11 Jun 2024 | OTHER | Deciphera Pharmaceuticals, Inc. | 286,075 | — | |
| 11 Jun 2024 | TENDER | Deciphera Pharmaceuticals, Inc. | 72,763 | — | |
| 11 Jun 2024 | OTHER | Deciphera Pharmaceuticals, Inc. | 270,357 | — | deriv |
| 11 Jun 2024 | OTHER | Deciphera Pharmaceuticals, Inc. | 250,000 | — | deriv |
| 11 Jun 2024 | OTHER | Deciphera Pharmaceuticals, Inc. | 395,735 | — | deriv |
| 11 Jun 2024 | OTHER | Deciphera Pharmaceuticals, Inc. | 298,100 | — | deriv |
| 11 Jun 2024 | OTHER | Deciphera Pharmaceuticals, Inc. | 415,000 | — | deriv |
| 15 Feb 2024 | GRANT_AWARD | Deciphera Pharmaceuticals, Inc. | 298,100 | 0.00 USD | deriv |
| 13 Dec 2023 | SALE | Deciphera Pharmaceuticals, Inc. | 30,664 | 15.37 USD | |
| 12 Dec 2023 | GRANT_AWARD | Deciphera Pharmaceuticals, Inc. | 62,500 | — | |
| 28 Oct 2023 | GRANT_AWARD | Deciphera Pharmaceuticals, Inc. | 62,500 | — | |
| 30 Oct 2023 | SALE | Deciphera Pharmaceuticals, Inc. | 21,573 | 12.02 USD |